Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000950123-10-003029
Filing Date
2010-01-15
Accepted
2010-01-15 17:11:43
Documents
4
Effectiveness Date
2010-01-15

Document Format Files

Seq Description Document Type Size
1 FORM S-8 g21769sv8.htm S-8 58281
2 EX-5.1 g21769exv5w1.htm EX-5.1 5862
3 EX-23.1 g21769exv23w1.htm EX-23.1 1786
4 EX-24.1 g21769exv24w1.htm EX-24.1 5359
  Complete submission text file 0000950123-10-003029.txt   72665
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: S-8 | Act: 33 | File No.: 333-164376 | Film No.: 10531109
SIC: 2834 Pharmaceutical Preparations